A SARS-CoV-2 Neutralizing Antibody Selected from COVID-19 Patients by Phage Display is Binding to the ACE2-RBD Interface and is Tolerant to Known RBD Mutations
暂无分享，去创建一个
S. Dübel | G. Roth | Thomas Klünemann | J. Heuvel | T. Schirrmann | M. Hust | A. Frenzel | U. Rand | P. Riese | L. Čičin-Šain | Marlies Becker | A. Hermann | P. Kuhn | Giulio Russo | F. Bertoglio | D. Meier | H. Garritsen | S. Steinke | Viola Fühner | M. Scholz | M. Schubert | P. A. Heine | G. Moreira | S. Casu | A. Koch | Rico Ballmann | E. Wenzel | Maximilian Ruschig | K. D. R. Roth | A. Gerstner | Nora Langreder | Kai-Thomas Schneider | J. Korn | Dorina Schäckermann | Susanne Zock-Emmenthal